Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products

被引:36
|
作者
Martegani, MP [1 ]
Del Prete, F [1 ]
Gasbarri, A [1 ]
Natali, PG [1 ]
Bartolazzi, A [1 ]
机构
[1] NCI Regina Elena, Dept Pathol & Immunol, I-00161 Rome, Italy
来源
AMERICAN JOURNAL OF PATHOLOGY | 1999年 / 154卷 / 01期
关键词
D O I
10.1016/S0002-9440(10)65275-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD44 can be considered structurally and functionally one of the most variable surface molecules. Alternative splicing of variant exons as well as posttranslational modifications of the molecule (differences in glycosylation) generate a rich repertoire of CD44 isoforms (CD44v), some of which seem to play a key role in tumor growth and progression. Immunodetection of CD44 isoforms in vivo, using mAbs specific for CD44 variant exon products, is largely used to identify those CD44 molecules involved in tumor growth and progression and to interfere with CD44-mediated processes, In the present work we demonstrate that the immunoreactivity of some mAbs directed to CD44 exon-specific epitopes can be impaired by the structural variability of the molecule. Our findings demonstrate that (1) specific exon assortment and/or posttranslational modifications of CD44v molecules can mask CD44 exon-specific epitopes; (2) glycosaminoglycan side chains, carried by some CD44v isoforms of high molecular weight, may play a critical role in determining the exact conformation of the molecule, which is necessary for the detection of CD44 variant epitopes by specific mAbs; and (3) in a panel of stable transfectants expressing CD44 N-glycosylation site-specific mutants, generated in the constant region of CD44 extracellular domain, asparagine-isoleucine substitution is sufficient per se to impair the immunoreactivity of several mAbs to pan-CD44. Thus, conformational changes due to the alternative splicing of CD44 variant exons and/or posttranslational modifications of the molecule (different degree of glycosylation), which are cell type-specific, are Likely to generate CD44 variants that elude immunodetection. These findings strongly suggest that immunohistochemical analysis of CD-44 expression in vitro and in vivo, using mAbs specific for CD44 variant exon epitopes, can potentially be impaired by a large number of false negative results.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 50 条
  • [1] EXPRESSION OF CD44 MOLECULES AND CD44 LIGANDS DURING HUMAN THYMIC FETAL DEVELOPMENT - EXPRESSION OF CD44 ISOFORMS IS DEVELOPMENTALLY-REGULATED
    PATEL, DD
    HALE, LP
    WHICHARD, LP
    RADCLIFF, G
    MACKAY, CR
    HAYNES, BF
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) : 277 - 286
  • [2] Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer
    Kawano, T
    Yanoma, S
    Nakamura, Y
    Ozeki, A
    Kokatsu, T
    Kubota, A
    Furukawa, M
    Tsukuda, M
    [J]. ACTA OTO-LARYNGOLOGICA, 2005, 125 (04) : 392 - 397
  • [3] CD44 standard (CD44s) and CD44 variant 6 (CD44v6) staining in ductal carcinoma in situ (DCIS)
    Barr, A
    Howes, G
    Humphreys, S
    [J]. JOURNAL OF PATHOLOGY, 1996, 179 : A19 - A19
  • [4] Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma
    Sagawa, K.
    Uwa, N.
    Daimon, T.
    Sakagami, M.
    Tsujimura, T.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (09): : 843 - 849
  • [5] CD44 isoforms, including the CD44 V3 variant, are expressed on endothelium, suggesting a role for CD44 in the immobilization of growth factors and the regulation of the local immune response
    Koopman, G
    Taher, TEI
    Mazzucchelli, I
    Keehnen, RMJ
    van der Voort, R
    Manten-Horst, E
    Ricevuti, G
    Pals, ST
    Das, PK
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) : 172 - 176
  • [6] Induction of hyaluronan binding to immune cells in CD44 deficient mice that selectively express CD44S or CD44V isoforms.
    Liao, HX
    Thomasch, JR
    Haynes, BF
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S190 - S190
  • [7] CD44
    Kremmidiotis, G
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1999, 13 (04): : 234 - 239
  • [8] CD44 variant isoforms associate with tetraspanins and EpCAM
    Schmidt, DS
    Klingbeil, P
    Schnölzer, M
    Zöller, M
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 297 (02) : 329 - 347
  • [9] EXPRESSION AND MODULATION OF CD44 VARIANT ISOFORMS IN HUMANS
    MACKAY, CR
    TERPE, HJ
    STAUDER, R
    MARSTON, WL
    STARK, H
    GUNTHERT, U
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 124 (1-2): : 71 - 82
  • [10] CD44 variant isoforms in skin transplantation.
    Buchner, S
    Tilgen, W
    Zoller, M
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 295 - 295